Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: DZOO who wrote (641)	4/6/1998 11:02:00 AM
From: FNS	Respond to of 965

The Avakine news doesn't appear to be that favorable! CNTO stock price took a nice bounce but has reversed to near lowest level! Is something amiss here??? SGC gets all marketing rights less USA, Japan, and far east portions. Tanabe Saikayu (sp?) has Japan/far east portions based on previous distributor agreement. (Didn't know about this!) So this means CNTO will market within USA. Could it be that the street was looking for 30 million and not 20 million up front? In any event, Avakine review/approval in May (?) is perhaps the key factor. FNS